Vivus revs up new Qsymia sales plan after FDA removes a roadblock

Tracy Staton Vivus’ weight-loss drug Qsymia–courtesy of Vivus. The FDA has agreed to take down one of the big hurdles hampering U.S. sales of Vivus’ newly ...

J&J pharma growth drives big increase in Q1 sales, profits

Tracy Staton Johnson & Johnson ($ JNJ) unveiled a street-beating set of first-quarter earnings. The drug and device maker posted net profits of $ 3.5 billion on sales of $ 17.5 ...

AbbVie to hack hundreds of reps from cardiovascular sales ranks

Tracy Staton AbbVie has a new distinction. It may be the youngest pharma company ever to lay off hundreds of salespeople. Bloomberg reports that the drugmaker, spun off by Abbott Laboratories ...

Avastin, Herceptin and Tamiflu power Roche to 6% sales growth in Q1

Tracy Staton Cancer and flu powered Roche to an impressive 13% increase in U.S. pharma sales for the first quarter–and 6% growth in overall sales. The effects of a nasty flu ...

Eli Lilly to lay off hundreds in sales as Cymbalta nears edge of patent cliff

Here is a business reality that hundreds of Eli Lilly ($ LLY) sales employees are going to have to align themselves with quite soon: They are about to lose their jobs. With its best-selling ...
Page 9 of 9« First...56789
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS